International Union of Basic and Clinical Pharmacology. CVI: GABAA receptor subtype-and function-selective ligands: key issues in translation to humans

W Sieghart, MM Savić - Pharmacological reviews, 2018 - ASPET
GABAA receptors are the major inhibitory transmitter receptors in the brain. They are ligand-
gated chloride channels and the site of action of benzodiazepines, barbiturates, neuroactive …

GABA-activated ligand gated ion channels: medicinal chemistry and molecular biology

M Chebib, GAR Johnston - Journal of medicinal chemistry, 2000 - ACS Publications
GABA (1, 4-aminobutanoic acid, γ-aminobutyric acid) is the major inhibitory neurotransmitter
in the brain and is essential for the overall balance between neuronal excitation and …

Structural Requirements for Eszopiclone and Zolpidem Binding to the γ-Aminobutyric Acid Type-A (GABAA) Receptor Are Different

SM Hanson, EV Morlock, KA Satyshur… - Journal of medicinal …, 2008 - ACS Publications
The sleep-aids zolpidem and eszopiclone exert their effects by binding to and modulating γ-
aminobutyric acid type-A receptors (GABAARs), but little is known about the structural …

The pharmacology and mechanisms of action of new generation, non-benzodiazepine hypnotic agents

DJ Sanger - CNS drugs, 2004 - Springer
The new generation hypnotic drugs, zolpidem, zopiclone and zaleplon, are at least as
efficacious in the clinic as benzodiazepines and may offer advantages in terms of safety …

Anxiolytic-like effects of sanjoinine A isolated from Zizyphi Spinosi Semen: Possible involvement of GABAergic transmission

H Han, Y Ma, JS Eun, RH Li, JT Hong, MK Lee… - Pharmacology …, 2009 - Elsevier
This experiment was performed to investigate the anxiolytic-like effects of sanjoinine A, one
of the major alkaloid compounds in Zizyphi Spinosi Semen (ZSS), by using experimental …

Anxioselective anxiolytics: on a quest for the Holy Grail

P Skolnick - Trends in pharmacological sciences, 2012 - cell.com
The discovery of benzodiazepine receptors provided the impetus to discover and develop
anxioselective anxiolytics ('Valium without the side effects'). The market potential for an …

Severe impairment of NMDA receptor function in mice carrying targeted point mutations in the glycine binding site results in drug-resistant nonhabituating hyperactivity

TM Ballard, M Pauly-Evers, GA Higgins… - Journal of …, 2002 - Soc Neuroscience
NMDA receptor hypofunction has been implicated in the pathophysiology of schizophrenia,
and pharmacological and genetic approaches have been used to model such dysfunction …

Indiplon is a high-affinity positive allosteric modulator with selectivity for α1 subunit-containing GABAA receptors

RE Petroski, JE Pomeroy, R Das, H Bowman… - … of Pharmacology and …, 2006 - ASPET
Indiplon (NBI 34060) is a novel pyrazolopyrimidine currently in development for the
treatment of insomnia. We have previously shown that indiplon exhibits high-affinity binding …

[图书][B] Arzneimitteltherapie in der Palliativmedizin

K Grüner, C Bausewein, C Rémi, R Twycross… - 2018 - books.google.com
Dieses Werk bietet praxisorientierte, konkrete Handlungsanweisungen mit exakten
Dosierungsangaben und zahlreichen Tipps für die tägliche Praxis. Es liefert präzise …

[HTML][HTML] Benzodiazepines

P Howard, R Twycross, J Shuster, M Mihalyo… - Journal of pain and …, 2014 - Elsevier
Therapeutic Reviews aim to provide essential independent information for health
professionals about drugs used in palliative and hospice care. Additional content is …